BioCentury | Oct 17, 2011
Clinical News

PCR KRas Assay regulatory update

...K-Ras gene in patients with colorectal cancer. The product is a real-time PCR-based K-Ras assay. China Medical Technologies Inc....
BioCentury | Aug 22, 2011
Clinical News

TOP2A FISH detection kit regulatory update

...State Food and Drug Administration (SFDA) approved China Medical's Topoisomerase 2-alpha (TOP2A) FISH detection kit. China Medical Technologies Inc....
BioCentury | Aug 22, 2011
Clinical News

Prostate Cancer FISH test regulatory update

...China's State Food and Drug Administration (SFDA) approved China Medical's Prostate Cancer FISH detection kit. China Medical Technologies Inc....
BioCentury | Aug 15, 2011
Company News

China Medical Technologies, Leica Microsystems deal

...option to sell the kits in the rest of the world. Details were not disclosed. China Medical Technologies Inc....
BioCentury | Dec 13, 2010
Financial News

China Medical Technologies financial update

...10 common shares. China Medical, which closed Friday at $11.49, has 322.7 million shares outstanding. China Medical Technologies Inc....
BioCentury | Dec 6, 2010
Financial News

China Medical Technologies completes private placement of senior convertible notes

China Medical Technologies Inc. (NASDAQ:CMED), Beijing, China Business: Diagnostic Date completed: 12/1/10 Type: Private placement of senior convertible notes Raised: $125 million Note: The unsecured notes bear 6.25% interest, mature on Dec. 15, 2016, and...
BioCentury | Nov 15, 2010
Clinical News

EGFR PCR Assay regulatory update

...China's State Food and Drug Administration (SFDA) approved China Medical Technologies' EGFR PCR Assay to provide a qualitative...
...common somatic mutations in the EGFR gene of patients with non-small cell lung cancer (NSCLC). China Medical Technologies Inc....
BioCentury | Nov 17, 2008
Clinical News

Breast Cancer HER-2 FISH regulatory update

...China's State Food and Drug Administration (SFDA) granted marketing approval to China Medical Technologies for its Breast Cancer...
...FISH probe to detect amplification of the HER-2 gene in human breast cancer tissue samples. China Medical Technologies Inc....
BioCentury | Oct 13, 2008
Company News

China Medical Technologies, Molecular Diagnostics Technologies Ltd. deal

...first fiscal quarter of 2009, which begins in April. Credit Suisse Ltd. advised China Medical. China Medical Technologies Inc....
Items per page:
1 - 9 of 9
BioCentury | Oct 17, 2011
Clinical News

PCR KRas Assay regulatory update

...K-Ras gene in patients with colorectal cancer. The product is a real-time PCR-based K-Ras assay. China Medical Technologies Inc....
BioCentury | Aug 22, 2011
Clinical News

TOP2A FISH detection kit regulatory update

...State Food and Drug Administration (SFDA) approved China Medical's Topoisomerase 2-alpha (TOP2A) FISH detection kit. China Medical Technologies Inc....
BioCentury | Aug 22, 2011
Clinical News

Prostate Cancer FISH test regulatory update

...China's State Food and Drug Administration (SFDA) approved China Medical's Prostate Cancer FISH detection kit. China Medical Technologies Inc....
BioCentury | Aug 15, 2011
Company News

China Medical Technologies, Leica Microsystems deal

...option to sell the kits in the rest of the world. Details were not disclosed. China Medical Technologies Inc....
BioCentury | Dec 13, 2010
Financial News

China Medical Technologies financial update

...10 common shares. China Medical, which closed Friday at $11.49, has 322.7 million shares outstanding. China Medical Technologies Inc....
BioCentury | Dec 6, 2010
Financial News

China Medical Technologies completes private placement of senior convertible notes

China Medical Technologies Inc. (NASDAQ:CMED), Beijing, China Business: Diagnostic Date completed: 12/1/10 Type: Private placement of senior convertible notes Raised: $125 million Note: The unsecured notes bear 6.25% interest, mature on Dec. 15, 2016, and...
BioCentury | Nov 15, 2010
Clinical News

EGFR PCR Assay regulatory update

...China's State Food and Drug Administration (SFDA) approved China Medical Technologies' EGFR PCR Assay to provide a qualitative...
...common somatic mutations in the EGFR gene of patients with non-small cell lung cancer (NSCLC). China Medical Technologies Inc....
BioCentury | Nov 17, 2008
Clinical News

Breast Cancer HER-2 FISH regulatory update

...China's State Food and Drug Administration (SFDA) granted marketing approval to China Medical Technologies for its Breast Cancer...
...FISH probe to detect amplification of the HER-2 gene in human breast cancer tissue samples. China Medical Technologies Inc....
BioCentury | Oct 13, 2008
Company News

China Medical Technologies, Molecular Diagnostics Technologies Ltd. deal

...first fiscal quarter of 2009, which begins in April. Credit Suisse Ltd. advised China Medical. China Medical Technologies Inc....
Items per page:
1 - 9 of 9